Patent ID: 11938158
Assignee: SOLAREA BIO, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. The dietary supplement of claim 1, wherein administration of the dietary supplement to the subject results in (i) altering the amount of at least one biochemical marker of bone turnover in the subject, and/or (ii) decreasing the amount of at least one circulatory inflammatory cytokine or marker of inflammation in the subject, wherein the amount of the at least one biochemical marker of bone turnover and/or at least one circulatory inflammatory cytokine or marker of inflammation is altered as compared to a suitable control; wherein the suitable control comprises: (a) a control group that has not been administered the dietary supplement, and/or (b) the amount of the at least one biochemical marker of bone turnover and/or the at least one circulatory inflammatory cytokine or marker of inflammation in the subject prior to the first administration of the dietary supplement.